 PHILADELPHIA, Sept. 30, 2021 GLOBE NEWSWIRE -- AnPac Bio-Medical Science Co., Ltd. AnPac Bio, the Company or we NASDAQ: ANPC, a biotechnology company with operations in the United States and China, announced today that it has received a written notification the Notification Letter from the Nasdaq Stock Market LLC Nasdaq dated September 24, 2021 indicating that the Company is not in compliance with the minimum Market Value of Listed Securities MVLS set forth in the Nasdaq Rules for continued listing on the Nasdaq Global Market. Nasdaq Listing Rule 5450b2A requires companies to maintain a minimum market value of US50,000,000 and Listing Rule 5810c3C provides that a failure to meet the market value requirement exists if the deficiency continues for a period of 30 consecutive business days. Based on the market value of the Company for the 30 consecutive business days from August 12, 2021 to September 23, 2021, the Company no longer meets the minimum market value requirement. This notification does not impact the listing and trading of the Companys securities at this time. 